Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin-Yu Perera

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Human Vaccines & Immunotherapeutics|June 22, 2013
Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infectionTod J Merkel, Pin-Yu Perera, Gloria M Lee, et al.
Vaccine|April 10, 2009
A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in micePin-Yu Perera, Steven C Derrick, Kristopher Kolibab, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytesSeiji Yokoyama, Nobumasa Watanabe, Noriko Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2010
Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entitiesTod J Merkel, Pin-Yu Perera, Vanessa K Kelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in miceLeo L M Poon, Y H Connie Leung, John M Nicholls, et al.
Nature Immunology|March 16, 2002
TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophagesVladimir Toshchakov, Bryan W Jones, Pin-Yu Perera, et al.
The Journal of Experimental Medicine|June 15, 2007
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axisZachary J Roberts, Nadege Goutagny, Pin-Yu Perera, et al.
Journal of Endotoxin Research|July 2, 2003
TLR2 and TLR4 agonists stimulate unique repertoires of host resistance genes in murine macrophages: interferon-beta-dependent signaling in TLR4-mediated responsesVladimir Toshchakov, Bryan W Jones, Arnd Lentschat, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Human Vaccines & Immunotherapeutics|June 22, 2013
Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infectionTod J Merkel, Pin-Yu Perera, Gloria M Lee, et al.
Vaccine|April 10, 2009
A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in micePin-Yu Perera, Steven C Derrick, Kristopher Kolibab, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytesSeiji Yokoyama, Nobumasa Watanabe, Noriko Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2010
Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entitiesTod J Merkel, Pin-Yu Perera, Vanessa K Kelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in miceLeo L M Poon, Y H Connie Leung, John M Nicholls, et al.
Nature Immunology|March 16, 2002
TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophagesVladimir Toshchakov, Bryan W Jones, Pin-Yu Perera, et al.
The Journal of Experimental Medicine|June 15, 2007
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axisZachary J Roberts, Nadege Goutagny, Pin-Yu Perera, et al.
Journal of Endotoxin Research|July 2, 2003
TLR2 and TLR4 agonists stimulate unique repertoires of host resistance genes in murine macrophages: interferon-beta-dependent signaling in TLR4-mediated responsesVladimir Toshchakov, Bryan W Jones, Arnd Lentschat, et al.
Pageof 2